Emmaus Life Sciences, Inc. SEC filings EMMA

Emmaus Life Sciences, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Sep 2, 2009. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
10-Q Quarterly report Sep 10, 2024 Jun 30, 2024
10-Q Quarterly report Sep 10, 2024 Mar 31, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
10-Q Quarterly report Sep 1, 2021 Jun 30, 2021
10-Q Quarterly report Sep 1, 2021 Mar 31, 2021
10-Q Quarterly report Aug 26, 2021 Jun 30, 2020
10-Q Quarterly report Aug 26, 2021 Sep 30, 2020
10-Q Quarterly report Aug 26, 2021 Mar 31, 2020
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019
10-Q Quarterly report May 13, 2019 Mar 31, 2019
10-Q Quarterly report Feb 14, 2019 Dec 31, 2018
10-Q Quarterly report Aug 10, 2018 Jun 30, 2018
10-Q Quarterly report May 14, 2018 Mar 31, 2018
10-Q Quarterly report Feb 20, 2018 Dec 31, 2017
10-Q Quarterly report Aug 14, 2017 Jun 30, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
10-Q/A Amended quarterly report Mar 30, 2017 Dec 31, 2016
10-Q Quarterly report Feb 14, 2017 Dec 31, 2016
10-Q Quarterly report Aug 15, 2016 Jun 30, 2016
10-Q Quarterly report May 16, 2016 Mar 31, 2016
10-Q Quarterly report Feb 17, 2016 Dec 31, 2015
10-Q Quarterly report Aug 14, 2015 Jun 30, 2015
10-Q/A Amended quarterly report May 18, 2015 Mar 31, 2015
10-Q Quarterly report May 15, 2015 Mar 31, 2015
10-Q Quarterly report Feb 13, 2015 Dec 31, 2014
10-Q Quarterly report Aug 14, 2014 Jun 30, 2014
10-Q Quarterly report May 15, 2014 Mar 31, 2014
10-Q Quarterly report Feb 13, 2014 Dec 31, 2013
10-Q Quarterly report Aug 14, 2013 Jun 30, 2013
10-Q Quarterly report May 15, 2013 Mar 31, 2013
10-Q/A Amended quarterly report Feb 22, 2013 Dec 31, 2012
10-Q Quarterly report Feb 19, 2013 Dec 31, 2012
10-Q/A Amended quarterly report Sep 11, 2012 Jun 30, 2012
10-Q Quarterly report Aug 14, 2012 Jun 30, 2012
10-Q Quarterly report May 15, 2012 Mar 31, 2012
10-Q Quarterly report Feb 14, 2012 Dec 31, 2011
10-Q/A Amended quarterly report Sep 9, 2011 Jun 30, 2011
10-Q Quarterly report Aug 15, 2011 Jun 30, 2011
10-Q Quarterly report May 16, 2011 Mar 31, 2011
10-Q Quarterly report Feb 14, 2011 Dec 31, 2010
10-Q Quarterly report Aug 16, 2010 Jun 30, 2010
10-Q Quarterly report May 14, 2010 Mar 31, 2010
10-Q Quarterly report Feb 16, 2010 Dec 31, 2009

Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EMMA (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Torrance, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
822370
Former names
MYnd Analytics, Inc. (until Jul 12, 2019); CNS RESPONSE, INC. (until Dec 10, 2015); STRATIVATION, INC. (until Mar 1, 2007); SalesTactix, Inc. (until Aug 23, 2005); AGE RESEARCH INC (until Aug 5, 2004)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.